As a clinician you play an important role in the rehabilitation of your patient. At Atos Medical we have a large portfolio of products available with a selection of clinical product eduction. Each patient needs to be approached individually to ensure he/she receives the products most suitable to him or her and knows how to use these products in the right way. To help you and the patient to get the most out of the products and use them in the best way possible, we have developed LaryLogics.
Latest Lit Alert
Our quarterly newsletter with trends, current information and literature regarding Atos products and their usage around the world. Below is the latest version to download.
- Talk-related effort and fatigue in laryngectomised patients
- Provox Vega XtraSeal
- Impact of communication changes on QoL
- Treatment related QoL in Latin American patients
- Preoperative factors associated with improved survival
- Tracheobronchitis in laryngectomised patients
- 13 years of prosthetic voice rehabilitation in the Netherlands
- Provox ActiValve and Biofilm formation
- Primary vs Secondary TEP
- Psychosocial factors and communication outcome
- Esophageal dysmotility after TL
- Tracheoesophageal whispering
Useful informational handouts that can be issued to patients to help support in their recovery.
LaryLogics are educational leaflets on a wide range of topics. We advise you to use these leaflets together with the patient to educate them on product use. Apart from the examples on our website, more LaryLogics are available. If you are interested in viewing those, please complete the form and you will get access to them.
- Insights on how to get a good breathing through a tracheostoma
- Guide on how to take daily care of your Voice Prosthesis
- Insights on how to get a good seal with Provox adhesives
- Introduction to Provox HMEs and their individual characteristics
Interested in getting more LaryLogics?
Rescue breathing for people with a laryngectomy
Laryngectomised people are neck breathers. Therefore oxygen and rescue breathing need to be administered to the person’s stoma and not to their mouths or noses.